Dr. Margot A. Schwartz, MD

Dr. Schwartz practices at Virginia Mason Medical Center - HOPD in Seattle, Washington.

Dr. Schwartz's NPI, 1275689267, was assigned on January 25, 2007. Dr. Schwartz graduated from The Johns Hopkins University School of Medicine in 1991. Dr. Schwartz's Washington license number on file is MD00031137.

Dr. Schwartz's primary practice is Virginia Mason Medical Center - HOPD, at 1100 9th Ave, Seattle, WA 98101.

Dr. Schwartz's primary practice is Virginia Mason Medical Center - HOPD in Seattle, Washington. Dr. Schwartz is also affiliated with Virginia Mason Medical Center. The medical group on file is Virginia Mason Medical Center. Dmand AI also links Dr. Schwartz to 2 more group practices and clinics, 1 imaging center and 1 medical group, each named with a free account. Dr. Schwartz's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schwartz practices, 5 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Schwartz's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Schwartz is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Schwartz's licenses on file in 2 states: Washington and Texas.

Dmand AI lists acute skin infection, hiv/aids and UTI among the conditions Dr. Schwartz treats.

CMS data shows 113 Medicare services from Dr. Schwartz across 4 procedure codes in 2024, for 61 Medicare patients. Medicare paid $9,123 for them.

CMS counts 61 Medicare patients who saw Dr. Schwartz in 2024. The largest group is 65 to 74, with 29 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schwartz's median patient age at 67, with 43% women.

In 2024, Dr. Schwartz wrote 610 Medicare Part D claims for 55 patients. 64% of them were for generic drugs. CMS names the drug for 457 of them, across 19 drugs with 11 or more claims each, at $726,468 in total drug cost. In 2023, CMS named 360 claims across 12 drugs.

Dr. Schwartz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schwartz as offering telehealth.

Dmand AI links 13 papers to Dr. Schwartz, published from 2000 to 2023. 2014 was the busiest year, with 2. The most frequent topics are Feces, Urethritis and Heterosexuality. Dr. Schwartz has published most often in Am J Gastroenterol. Dr. Schwartz's most frequent co-authors are Michael Gluck, MD, Lawrence J. Brandt, MD and Anthony J. Gerbino, MD.

Dmand AI lists 1 award for Dr. Schwartz, most recently CMS Stage 1 EHR in 2013.

Dr. Schwartz graduated from The Johns Hopkins University School of Medicine in 1991. Dr. Schwartz is a member of ACP.

Dr. Schwartz is in network with 15 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.